858O Results of KEYNOTE-122: A phase III study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)
| Autor: | Chan, A.T., Lee, V.H.F., Hong, R-L., Ahn, M-J., Chong, W.Q., Kim, S-B., Gwo Fuang, H., Caguioa, P.B., Ngamphaiboon, N., Ho, C., Abdul Aziz, M.A.S., Ng, Q.S., Yen, C-J., Soparattanapaisarn, N., Ngan, K.C.R., Kho, S.K., Swaby, R., Saraf, S., Ge, J., Siu, L.L. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S786-S786 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|